Van de Plas Pharma SRL
0.5 FTEVan de Plas Pharma reported total assets of 566,351 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Jul 2026), with 0.5 full-time equivalent.
The score of Van de Plas Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +130 % Total assets +11 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Van de Plas Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −26,266 € | ||||
| Equity | 110,648 € | ||||
| Cash | 34,026 € | ||||
| EBITDA | 9,466 € | ||||
| Total assets | 566,351 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Jul 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Dec 2023filed on 15 Jul 2024
- Year ended 31 Dec 2022filed on 28 Jun 2023
- Year ended 31 Dec 2021filed on 28 Jul 2022
Van de Plas Pharma's financial analysis
- Solvency19.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Van de Plas Pharma
Van de Plas Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0437.942.825
- VAT number
- BE0437942825
- Peppol
- Registered · 0208:0437942825 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Jun 1989
- Registered office
- 1640 Sint-Genesius-Rode
- Size
- Micro · 0.5 FTE
- Latest accounts
- 2025 · filed on 10 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Van de Plas Pharma (SRL) has been based in Sint-Genesius-Rode since 1989, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 26,266 € and equity of 110,648 €; its revenue is not published. With 0.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 19.5%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Van de Plas Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Cawet - Swalue Retail sale of pharmaceutical products Chimay · balance sheet 565,492 €
- Infiphar Retail sale of pharmaceutical products Tienen · balance sheet 565,355 €
- Vasseur-Sevrin Retail sale of pharmaceutical products Chastre · balance sheet 567,446 €
- Apoteek Termote Retail sale of pharmaceutical products Waasmunster · balance sheet 565,154 €
- Apotheek - Pharmacie Bollen Retail sale of pharmaceutical products Evere · balance sheet 565,052 €
- Sonapha Retail sale of pharmaceutical products Vaux-sur-Sûre · balance sheet 568,273 €
- Stragier Retail sale of pharmaceutical products Ath · balance sheet 562,496 €
- Pharm@dvice Retail sale of pharmaceutical products Fexhe-le-Haut-Clocher · balance sheet 571,791 €
Frequently asked questions about Van de Plas Pharma
What is the revenue of Van de Plas Pharma?
Van de Plas Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Van de Plas Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0437942825 for Van de Plas Pharma, if the company is VAT-registered. Its company number (CBE) is 0437.942.825.
Where is the registered office of Van de Plas Pharma?
According to the CBE register, the registered office of Van de Plas Pharma is in 1640 Sint-Genesius-Rode.
What is the equity of Van de Plas Pharma?
At the close of the 2025 financial year, the equity of Van de Plas Pharma amounts to 110,648 €, a solvency of 19.5% of total assets.
How many people work at Van de Plas Pharma?
0.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Van de Plas Pharma?
The register lists 2 active mandates at Van de Plas Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Van de Plas Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →